Birmingham Health Innovation Campus takes another step forward after planning permission granted

Work is set to begin on the first phase of Birmingham Health Innovation Campus this Summer after planning permission was granted by Birmingham City Council. The first phase will see the development of No.1 Birmingham Health Innovation Campus which will offer 133,000 sq ft of lab and office space purposely designed for health innovation and … Continue reading “Birmingham Health Innovation Campus takes another step forward after planning permission granted”

Alternating Covid-19 vaccine dose study launches in Birmingham

Researchers running the Com-Cov study investigating alternating doses of the Oxford-AstraZeneca vaccine and the Pfizer vaccine, have announced a new study in Birmingham now including the Moderna and Novavax vaccines. The additional study will seek to recruit adults aged over 50 who have received their first, or ‘prime’ vaccination in the past 8-12 weeks, and … Continue reading “Alternating Covid-19 vaccine dose study launches in Birmingham”

Cellular responses enhanced in over 80s after AstraZeneca vaccine

Over-80s show similar antibody responses following single vaccination with either Pfizer or AstraZeneca vaccine – but cellular responses are enhanced after AstraZeneca vaccine People aged over 80 receiving a single dose of either the Pfizer or AstraZeneca COVID vaccine show equivalent antibody responses five weeks post vaccination. However, stronger cellular (T cell) responses were seen … Continue reading “Cellular responses enhanced in over 80s after AstraZeneca vaccine”

COVID-19 lateral flow testing survey is launched for the city of Birmingham

BHP founder-member the University of Birmingham and Birmingham City Council have launched a research project to improve people’s experiences of Lateral Flow Testing for COVID-19 in Birmingham. Led by the Institute of Applied Health Research at the University, the survey will target adults residing in the city who have had a lateral flow tests (LFT) taken … Continue reading “COVID-19 lateral flow testing survey is launched for the city of Birmingham”

98% of over 80s have strong antibody response after second Pfizer dose

A study led by BHP founder-member the University of Birmingham and supported by the UK Coronavirus Immunology Consortium has found that 98% of people aged 80 or over who had two doses of the Pfizer COVID-19 vaccine had a strong antibody immune response. The research involved 100 people aged 80 to 96, who were living … Continue reading “98% of over 80s have strong antibody response after second Pfizer dose”